Seres Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 21,977 | 0.0145% |
Individual Insiders | 1,260,172 | 0.832% |
Public Companies | 7,496,038 | 4.95% |
VC/PE Firms | 23,117,045 | 15.3% |
General Public | 56,771,411 | 37.5% |
Institutions | 62,781,120 | 41.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
23,117,045 | US$21.0m | 0% | 1.25% | |||
22,651,419 | US$20.6m | 16.8% | no data | |||
7,496,038 | US$6.8m | 0% | no data | |||
6,825,399 | US$6.2m | -7% | no data | |||
6,734,821 | US$6.1m | 12.2% | no data | |||
5,425,000 | US$4.9m | 25.6% | 0.05% | |||
2,132,643 | US$1.9m | 1.84% | no data | |||
2,045,871 | US$1.9m | 58.6% | 0.02% | |||
1,946,363 | US$1.8m | 1.93% | no data | |||
1,652,162 | US$1.5m | -30% | no data | |||
1,388,944 | US$1.3m | -20.8% | 0.09% | |||
1,100,000 | US$1.0m | 0% | no data | |||
1,027,552 | US$935.2k | -53.8% | no data | |||
1,021,906 | US$930.0k | 155% | no data | |||
907,112 | US$825.6k | -49.4% | 0.09% | |||
784,693 | US$714.2k | 1.83% | no data | |||
747,318 | US$680.1k | 10.5% | no data | |||
634,603 | US$577.5k | -55% | no data | |||
486,353 | US$442.6k | 189% | no data | |||
464,970 | US$423.2k | -45.8% | no data | |||
342,200 | US$311.4k | 0% | 0.01% | |||
340,761 | US$310.1k | 0% | 0.91% | |||
329,072 | US$299.5k | -4.43% | no data | |||
309,379 | US$281.6k | 91.8% | 0.02% | |||
298,111 | US$271.3k | -18% | no data |